Bicara Therapeutics Reports Promising Phase 1/1b Trial Results for Ficerafusp Alfa in HPV-Negative Head and Neck Cancer
1/6 19:20
Bicara Therapeutics reports encouraging Phase 1/1b results for ficerafusp alfa in HPV-negative head and neck cancer patients....